Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sativex for pain and symptom burden in end-stage renal disease
ACTRN12610000783022Phase 4Terminated
- Sponsor
- Northern Alberta Renal Program
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic pain comparing Sativex with Matched placebo (2 arms). Primary endpoint: Pain response by numerical rating scale. Started Oct 2011; status: terminated.
02
Drugs
cannabidiol
03
Conditions
chronic pain
Beyond the preview
Go deeper on ACTRN12610000783022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000783022.